| Year |
Citation |
Score |
| 2020 |
Rosenbluth JM, Schackmann RCJ, Gray GK, Selfors LM, Li CM, Boedicker M, Kuiken HJ, Richardson A, Brock J, Garber J, Dillon D, Sachs N, Clevers H, Brugge JS. Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages. Nature Communications. 11: 1711. PMID 32249764 DOI: 10.1038/S41467-020-15548-7 |
0.301 |
|
| 2019 |
Harris IS, Endress JE, Coloff JL, Selfors LM, McBrayer SK, Rosenbluth JM, Takahashi N, Dhakal S, Koduri V, Oser MG, Schauer NJ, Doherty LM, Hong AL, Kang YP, Younger ST, et al. Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion. Cell Metabolism. PMID 30799286 DOI: 10.1016/J.Cmet.2019.01.020 |
0.422 |
|
| 2019 |
Rosenbluth J, Zervantonakis I, Boedicker M, Wagle N, Dillon D, Nakhlis F, Brugge J, Overmoyer B. Abstract P5-17-01: Patient-derived organoid models of inflammatory breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P5-17-01 |
0.335 |
|
| 2018 |
Jacene HA, Youn T, DiPiro PJ, Hu J, Cheng SC, Franchetti Y, Shah H, Bellon JR, Warren L, Schlosnagle E, Nakhlis F, Rosenbluth J, Yeh E, Overmoyer B. Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade. Clinical Breast Cancer. PMID 30584057 DOI: 10.1016/J.Clbc.2018.11.010 |
0.309 |
|
| 2018 |
Rosenbluth JM, Schackmann R, Li C, Sachs N, Dillon D, Richardson A, Brock J, Garber J, Gray GK, Zoeller J, Boedicker M, Kuiken HJ, Clevers H, Brugge J. Abstract 989: Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages and can form chimeric mammary glands in vivo Cancer Research. 78: 989-989. DOI: 10.1158/1538-7445.Am2018-989 |
0.317 |
|
| 2017 |
Jovanovic B, Mayer IA, Mayer EL, Abramson VG, Bardia A, Sanders M, Kuba MG, Estrada MV, Beeler JS, Shaver TM, Johnson KN, Sanchez V, Rosenbluth JM, Dillon PM, Forrero-Torres A, et al. A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus in patients with stage II/III triple-negative breast cancer (TNBC). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28270498 DOI: 10.1158/1078-0432.Ccr-16-3055 |
0.572 |
|
| 2016 |
Marshall CB, Mays DJ, Beeler JS, Rosenbluth JM, Boyd KL, Santos Guasch GL, Shaver TM, Tang LJ, Liu Q, Shyr Y, Venters BJ, Magnuson MA, Pietenpol JA. p73 Is Required for Multiciliogenesis and Regulates the Foxj1-Associated Gene Network. Cell Reports. PMID 26947080 DOI: 10.1016/J.Celrep.2016.02.035 |
0.726 |
|
| 2011 |
Rosenbluth JM, Mays DJ, Jiang A, Shyr Y, Pietenpol JA. Differential regulation of the p73 cistrome by mammalian target of rapamycin reveals transcriptional programs of mesenchymal differentiation and tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America. 108: 2076-81. PMID 21245298 DOI: 10.1073/Pnas.1011936108 |
0.725 |
|
| 2010 |
Eby KG, Rosenbluth JM, Mays DJ, Marshall CB, Barton CE, Sinha S, Johnson KN, Tang L, Pietenpol JA. ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy. Molecular Cancer. 9: 95. PMID 20429933 DOI: 10.1186/1476-4598-9-95 |
0.392 |
|
| 2010 |
Bauer JA, Chakravarthy AB, Rosenbluth JM, Mi D, Seeley EH, De Matos Granja-Ingram N, Olivares MG, Kelley MC, Mayer IA, Meszoely IM, Means-Powell JA, Johnson KN, Tsai CJ, Ayers GD, Sanders ME, et al. Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 681-90. PMID 20068102 DOI: 10.1158/1078-0432.Ccr-09-1091 |
0.593 |
|
| 2009 |
Rosenbluth JM, Johnson K, Tang L, Triplett T, Pietenpol JA. Evaluation of p63 and p73 antibodies for cross-reactivity. Cell Cycle (Georgetown, Tex.). 8: 3702-6. PMID 19855172 DOI: 10.4161/Cc.8.22.10036 |
0.713 |
|
| 2009 |
Rosenbluth JM, Pietenpol JA. mTOR regulates autophagy-associated genes downstream of p73. Autophagy. 5: 114-6. PMID 19001857 DOI: 10.4161/Auto.5.1.7294 |
0.763 |
|
| 2008 |
Rosenbluth JM, Pietenpol JA. The jury is in: p73 is a tumor suppressor after all. Genes & Development. 22: 2591-5. PMID 18832062 DOI: 10.1101/Gad.1727408 |
0.715 |
|
| 2008 |
Rosenbluth JM, Mays DJ, Pino MF, Tang LJ, Pietenpol JA. A gene signature-based approach identifies mTOR as a regulator of p73. Molecular and Cellular Biology. 28: 5951-64. PMID 18678646 DOI: 10.1128/Mcb.00305-08 |
0.715 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2006 |
Kaga Y, Shoemaker WJ, Furusho M, Bryant M, Rosenbluth J, Pfeiffer SE, Oh L, Rasband M, Lappe-Siefke C, Yu K, Ornitz DM, Nave KA, Bansal R. Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 12339-50. PMID 17122059 DOI: 10.1523/Jneurosci.3573-06.2006 |
0.293 |
|
| 2000 |
Harroch S, Palmeri M, Rosenbluth J, Custer A, Okigaki M, Shrager P, Blum M, Buxbaum JD, Schlessinger J. No obvious abnormality in mice deficient in receptor protein tyrosine phosphatase beta. Molecular and Cellular Biology. 20: 7706-15. PMID 11003666 DOI: 10.1128/Mcb.20.20.7706-7715.2000 |
0.277 |
|
| 2019 |
Rosenbluth JM, Overmoyer BA. Inflammatory Breast Cancer: a Separate Entity. Current Oncology Reports. 21: 86. PMID 31414257 DOI: 10.1007/S11912-019-0842-Y |
0.249 |
|
| 2022 |
Gray GK, Li CM, Rosenbluth JM, Selfors LM, Girnius N, Lin JR, Schackmann RCJ, Goh WL, Moore K, Shapiro HK, Mei S, D'Andrea K, Nathanson KL, Sorger PK, Santagata S, et al. A human breast atlas integrating single-cell proteomics and transcriptomics. Developmental Cell. PMID 35617956 DOI: 10.1016/j.devcel.2022.05.003 |
0.241 |
|
| 2019 |
Sarkizova S, Klaeger S, Le PM, Li LW, Oliveira G, Keshishian H, Hartigan CR, Zhang W, Braun DA, Ligon KL, Bachireddy P, Zervantonakis IK, Rosenbluth JM, Ouspenskaia T, Law T, et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nature Biotechnology. PMID 31844290 DOI: 10.1038/S41587-019-0322-9 |
0.238 |
|
| 2023 |
Nguyen HP, Sheng R, Murray E, Ito Y, Bruck M, Biellak C, An K, Lynce F, Dillon DA, Magbanua MJM, Huppert LA, Hammerlindl H, Esserman L, Rosenbluth JM, Ahituv N. Implantation of engineered adipocytes that outcompete tumors for resources suppresses cancer progression. Biorxiv : the Preprint Server For Biology. PMID 37034710 DOI: 10.1101/2023.03.28.534564 |
0.225 |
|
| 2020 |
Li CM, Shapiro H, Tsiobikas C, Selfors LM, Chen H, Rosenbluth J, Moore K, Gupta KP, Gray GK, Oren Y, Steinbaugh MJ, Guerriero JL, Pinello L, Regev A, Brugge JS. Aging-Associated Alterations in Mammary Epithelia and Stroma Revealed by Single-Cell RNA Sequencing. Cell Reports. 33: 108566. PMID 33378681 DOI: 10.1016/j.celrep.2020.108566 |
0.222 |
|
| 2020 |
Jacene HA, DiPiro PJ, Bellon J, Hu J, Cheng SC, Warren L, Schlosnagle E, Nakhlis F, Rosenbluth JM, Yeh E, Overmoyer B. Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning. Breast Cancer Research and Treatment. PMID 32318957 DOI: 10.1007/S10549-020-05631-4 |
0.217 |
|
| 1996 |
Rosenbluth J, Liang W, Liu Z, Guo D, Schiff R. Expanded CNS myelin sheaths formed in situ in the presence of an IgM antigalactocerebroside-producing hybridoma The Journal of Neuroscience. 16: 2635-2641. DOI: 10.1523/Jneurosci.16-08-02635.1996 |
0.199 |
|
| 2021 |
Hirko KA, Regan MM, Remolano MC, Schlossman J, Harrison B, Yeh E, Jacene H, Nakhlis F, Block C, Rosenbluth JM, Garrido-Castro AC, Overmoyer BA. Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer. American Journal of Clinical Oncology. PMID 34149037 DOI: 10.1097/COC.0000000000000843 |
0.145 |
|
| 2023 |
Garrido-Castro AC, Regan MM, Niman SM, Nakhlis F, Remolano C, Rosenbluth JM, Block C, Warren LE, Bellon JR, Yeh E, Harrison BT, Troll E, Lin NU, Tolaney SM, Overmoyer B, et al. Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer. Npj Breast Cancer. 9: 50. PMID 37268625 DOI: 10.1038/s41523-023-00555-w |
0.109 |
|
| 2021 |
Dekkers JF, van Vliet EJ, Sachs N, Rosenbluth JM, Kopper O, Rebel HG, Wehrens EJ, Piani C, Visvader JE, Verissimo CS, Boj SF, Brugge JS, Clevers H, Rios AC. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nature Protocols. PMID 33692550 DOI: 10.1038/s41596-020-00474-1 |
0.096 |
|
| 2020 |
White RE, Warren L, Nakhlis F, Rosenbluth J, Bellon J, Block C, Overmoyer B. Characteristics associated with inflammatory breast cancer (IBC): An epidemiologic study from a dedicated IBC program. The Breast Journal. PMID 32875655 DOI: 10.1111/tbj.14030 |
0.096 |
|
| 2022 |
Glencer AC, Miller PN, Greenwood H, Maldonado Rodas CK, Freimanis R, Basu A, Mukhtar RA, Brabham C, Kim P, Hwang ES, Rosenbluth JM, Hirst GL, Campbell MJ, Borowsky AD, Esserman LJ. Identifying Good Candidates for Active Surveillance of Ductal Carcinoma : Insights from a Large Neoadjuvant Endocrine Therapy Cohort. Cancer Research Communications. 2: 1579-1589. PMID 36970720 DOI: 10.1158/2767-9764.CRC-22-0263 |
0.091 |
|
| 2010 |
Rosenbluth JM. Pandemic response: developing a mission-critical inventory and cross-training programme. Journal of Business Continuity & Emergency Planning. 4: 126-31. PMID 20494877 |
0.036 |
|
| Hide low-probability matches. |